Clinical Trials
24 trialsNCT07218068 2025-11-03
IPDP
Wake Forest University Health Sciences
Phase EARLY_PHASE1 Completed
NCT05678348 2025-08-17
Pyrimethamine as an Inhibitor of NRF2 in HPV-unrelated Locally Advanced Head and Neck Squamous Cell Carcinoma
Washington University School of Medicine
Phase EARLY_PHASE1 Completed
NCT05278260 2025-05-14
Hydrogen-rich Water and Treatment of Mucositis Caused by Radiation Therapy in Head and Neck Cancer Patients
Stony Brook University
Phase EARLY_PHASE1 Completed
NCT04188951 2024-12-04
HFHS-1801-A Pilot Study of Immunotherapy As Consolidation Therapy for Patients with Recurrent Head and Neck Cancer
Henry Ford Health System
Phase EARLY_PHASE1 Completed
NCT06413095 2024-05-14
PBI-MST-01 (NCT04541108) Substudy MSD-03: Intratumoral Microdosing of Pembrolizumab Alone and With MK-0482 or MK-4830 in HNSCC or STS
Presage Biosciences
Phase EARLY_PHASE1 Completed
NCT06062602 2023-10-06
PBI-MST-01(NCT04541108) Substudy TAK-02: Intratumoral Microdosing of TAK-676 in HNSCC
Presage Biosciences
Phase EARLY_PHASE1 Completed
NCT03282461 2023-05-18
A Microdose Evaluation Study of ABY-029 in Head and Neck Oncology Surgery
Dartmouth-Hitchcock Medical Center
Phase EARLY_PHASE1 Completed
NCT04065555 2022-07-29
Intratumoral Microdosing of TAK-981 in Head and Neck Cancer
Presage Biosciences
Phase EARLY_PHASE1 Completed
NCT01434342 2021-09-28
Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients
Wake Forest University Health Sciences
Phase EARLY_PHASE1 Completed
NCT03317730 2021-07-20
RAD 1702
University of Alabama at Birmingham
Phase EARLY_PHASE1 Completed
NCT03182959 2021-06-21
Broccoli Sprout Extract in Preventing Recurrence in Patients With Tobacco-Related Head and Neck Squamous Cell Cancer
University of Arizona
Phase EARLY_PHASE1 Completed
NCT02794675 2020-12-23
Intraoperative Placement of Cesium-131 Permanent Interstitial Brachytherapy in Head and Neck Cancer
Case Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed
NCT01359267 2020-05-08
Feasibility of Imaging in the Treatment of Patients With Advanced Head and Neck Cancer
University of Chicago
Phase EARLY_PHASE1 Completed
NCT00601913 2018-07-05
Erlotinib and Surgery in Treating Patients With Head and Neck Cancer That Can Be Removed by Surgery
Wake Forest University Health Sciences
Phase EARLY_PHASE1 Completed
NCT02023931 2017-11-13
BSE
University of Pittsburgh
Phase EARLY_PHASE1 Completed
NCT00757549 2017-10-31
3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT00395109 2017-08-28
PET/CT to Image Hypoxia in Head and Neck Tumours
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase EARLY_PHASE1 Completed
NCT00723463 2016-11-02
Determine if Apparent Diffusion Coefficient (ADC) Values Can Differentiate Tumors From Normal Tissue
University of Michigan
Phase EARLY_PHASE1 Completed
NCT01160302 2016-03-02
Curcumin Biomarker Trial in Head and Neck Cancer
Louisiana State University Health Sciences Center Shreveport
Phase EARLY_PHASE1 Completed
NCT00696176 2015-07-23
STAT3 DECOY in Head and Neck Cancer
University of Pittsburgh
Phase EARLY_PHASE1 Completed
NCT01275183 2015-06-18
Pilot Study of Raltegravir and Cisplatin in Squamous Cell Carcinoma of Head and Neck
New Mexico Cancer Research Alliance
Phase EARLY_PHASE1 Completed
NCT00140556 2013-01-18
Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer
Duke University
Phase EARLY_PHASE1 Completed
NCT00884520 2010-03-16
VM4-037
Siemens Molecular Imaging
Phase EARLY_PHASE1 Completed
NCT00606424 2009-02-02
HX4
Siemens Molecular Imaging
Phase EARLY_PHASE1 Completed